HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques

Dominant antibody responses in vaccinees who received the HIV-1 multiclade (A, B, and C) envelope (Env) DNA/recombinant adenovirus virus type 5 (rAd5) vaccine studied in HIV-1 Vaccine Trials Network (HVTN) efficacy trial 505 (HVTN 505) targeted Env gp41 and cross-reacted with microbial antigens. In...

詳細記述

保存先:
書誌詳細
出版年:J Virol
主要な著者: Han, Qifeng, Williams, Wilton B., Saunders, Kevin O., Seaton, Kelly E., Wiehe, Kevin J., Vandergrift, Nathan, Von Holle, Tarra A., Trama, Ashley M., Parks, Robert J., Luo, Kan, Gurley, Thaddeus C., Kepler, Thomas B., Marshall, Dawn J., Montefiori, David C., Sutherland, Laura L., Alam, Munir S., Whitesides, John F., Bowman, Cindy M., Permar, Sallie R., Graham, Barney S., Mascola, John R., Seed, Patrick C., Van Rompay, Koen K. A., Tomaras, Georgia D., Moody, M. Anthony, Haynes, Barton F.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2017
主題:
Vaccines and Antiviral Agents
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640856/
https://ncbi.nlm.nih.gov/pubmed/28794027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00923-17
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料